PharmaMar announces data presentations for both its molecules Yondelis® and lurbinectedin at ASCO 2018
(WorldNews Europe)

Abstracts #11519 #1072 #8570 #TPS8587 #2551 #11513 #11544 #11566 #TPS11591 #11508 #8018 PharmaMar announces data presentations for both its molecules Yondelis® and lurbinectedin at ASCO 2018 o Yondelis®: oral presentation of a comparative study in soft tissue sarcoma (T-SAR) between trabectedin versus best supportive care; and, a study in combination with immunotherapy. o Lurbinectedin: the clinical advances made in Small Cell Lung Cancer, Ewing´s sarcoma, and breast cancer. o Plitidepsin: overall survival data from the ADMYRE study in patients with relapsed/refractory multiple myeloma. Madrid, 17th of May, 2018.- During the Congress of the American Society of Clinical Oncology (ASCO) that...